Dr. Ron A Lepianka is a North Chicago, Illinois based Prosthodontics who is specialized in Prosthetic Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3001 Green Bay Road, North Chicago. Patients can reach him at 847-688-1900.
Dr. Ron A Lepianka specialized in that branch of dentistry pertaining to the restoration and maintenance of oral functions, comfort, appearance and health of the patient by the restoration of natural teeth and/or the replacement of missing teeth and contiguous oral and maxillofacial tissues with artificial substitutes.
Complete Profile:
Dr. Ron A Lepianka speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Ron A Lepianka
Specialization:
Prosthodontics
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
3001 Green Bay Road, North Chicago, Illinois, 60064
Phone:
847-688-1900
Fax:
224-610-2909
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
2163661927
Enrollment ID:
I20130627000108
NPI Number:
1912964461
NPI Enumeration Date:
27 Apr, 2006
NPI Last Update On:
18 Sep, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7266 Presidential Dr, Gurnee, Illinois
Zip:
60031-5302
Phone Number:
847-688-1900
Fax Number:
224-610-2909
Patients can reach Dr. Ron A Lepianka at 3001 Green Bay Road, North Chicago, Illinois or can call to book an appointment on 847-688-1900. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.